Cover and Content | |
1-4 |
Achieving a Longer Duration of Peritoneal Dialysis Replacement Treatment in Patients with CKD | |
Darina Damyanova, Boryana Ivanova, Svetla Staykova, Rossitsa Zorchevа | 5-10 |
COVID-19-Associated Nephropathy | |
Liliya Stoyanova | 11-16 |
Replacement Treatment with Peritoneal Dialysis in CKD—Significance of Diabetes Mellitus | |
Boryana Ivanova, Darina Damyanova, Svetla Staykova, Rossitsa Zorcheva | 17-22 |
Correlative Interactions Between Visfatin and Inflammatory Biomarkers for Chronic Kidney Disease | |
Petar Petrov, Miroslava Benkova-Petrova, Hristo Petrov, Dobromir Staykov | 23-27 |
Tubulopathy in Patients with Beta Thalassemia Major | |
Liliya Stoyanova, Svetla Staykova, Triphon Chervenkov | 28-33 |
Kinesitherapy for Patients on Hemodialysis | |
Magdalena Bliznakova, Irina Momcheva, Ivelina Hristova, Eva Hristova, Zhenya Ruseva, Valentina Madjova | 34-37 |
The COVID-19 Pandemic and Concequences for the Kidneys | |
Ivelina Dudrenova | 38-43 |
Evaluation of Dialysis Adequacy in Real Time by Ionic Dialysis—Reliability and Comparability of the Method | |
Diana Nenova | 44-50 |